Upcoming FDA Workshops:
Nov. 18, 2016: FDA-Johns Hopkins CERSI Co-sponsored Workshop on Substitutability of Generic Drugs: Perceptions and Reality
This workshop will:
- Discuss current progress on generic drug surveillance method development, generic substitution study outcomes, and surveys about generic drugs
- Build confidence in generic drugs by demonstrating FDA’s commitment to monitoring generic drugs in the postmarket setting and presenting evidence to confirm equivalency
- Provide timely communication of the results of postmarket research related to generic drugs
- Identify future research needs in postmarket surveillance of generic drugs.